Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals

An overwhelming body of evidence stating that the completeness of reporting of randomised controlled trials (RCTs) is not optimal has accrued over time. In the mid-1990s, in response to these concerns, an international group of clinical trialists, statisticians, epidemiologists, and biomedical journ...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Cochrane database of systematic reviews Ročník 11; s. MR000030
Hlavní autori: Turner, Lucy, Shamseer, Larissa, Altman, Douglas G, Weeks, Laura, Peters, Jodi, Kober, Thilo, Dias, Sofia, Schulz, Kenneth F, Plint, Amy C, Moher, David
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England 14.11.2012
Predmet:
ISSN:1469-493X, 1469-493X
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract An overwhelming body of evidence stating that the completeness of reporting of randomised controlled trials (RCTs) is not optimal has accrued over time. In the mid-1990s, in response to these concerns, an international group of clinical trialists, statisticians, epidemiologists, and biomedical journal editors developed the CONsolidated Standards Of Reporting Trials (CONSORT) Statement. The CONSORT Statement, most recently updated in March 2010, is an evidence-based minimum set of recommendations including a checklist and flow diagram for reporting RCTs and is intended to facilitate the complete and transparent reporting of trials and aid their critical appraisal and interpretation. In 2006, a systematic review of eight studies evaluating the "effectiveness of CONSORT in improving reporting quality in journals" was published. To update the earlier systematic review assessing whether journal endorsement of the 1996 and 2001 CONSORT checklists influences the completeness of reporting of RCTs published in medical journals. We conducted electronic searches, known item searching, and reference list scans to identify reports of evaluations assessing the completeness of reporting of RCTs. The electronic search strategy was developed in MEDLINE and tailored to EMBASE. We searched the Cochrane Methodology Register and the Cochrane Database of Systematic Reviews using the Wiley interface. We searched the Science Citation Index, Social Science Citation Index, and Arts and Humanities Citation Index through the ISI Web of Knowledge interface. We conducted all searches to identify reports published between January 2005 and March 2010, inclusive. In addition to studies identified in the original systematic review on this topic, comparative studies evaluating the completeness of reporting of RCTs in any of the following comparison groups were eligible for inclusion in this review: 1) Completeness of reporting of RCTs published in journals that have and have not endorsed the CONSORT Statement; 2) Completeness of reporting of RCTs published in CONSORT-endorsing journals before and after endorsement; or 3) Completeness of reporting of RCTs before and after the publication of the CONSORT Statement (1996 or 2001). We used a broad definition of CONSORT endorsement that includes any of the following: (a) requirement or recommendation in journal's 'Instructions to Authors' to follow CONSORT guidelines; (b) journal editorial statement endorsing the CONSORT Statement; or (c) editorial requirement for authors to submit a CONSORT checklist and/or flow diagram with their manuscript. We contacted authors of evaluations reporting data that could be included in any comparison group(s), but not presented as such in the published report and asked them to provide additional data in order to determine eligibility of their evaluation. Evaluations were not excluded due to language of publication or validity assessment. We completed screening and data extraction using standardised electronic forms, where conflicts, reasons for exclusion, and level of agreement were all automatically and centrally managed in web-based management software, DistillerSR(®). One of two authors extracted general characteristics of included evaluations and all data were verified by a second author. Data describing completeness of reporting were extracted by one author using a pre-specified form; a 10% random sample of evaluations was verified by a second author. Any discrepancies were discussed by both authors; we made no modifications to the extracted data. Validity assessments of included evaluations were conducted by one author and independently verified by one of three authors. We resolved all conflicts by consensus.For each comparison we collected data on 27 outcomes: 22 items of the CONSORT 2001 checklist, plus four items relating to the reporting of blinding, and one item of aggregate CONSORT scores. Where reported, we extracted and qualitatively synthesised data on the methodological quality of RCTs, by scale or score. Fifty-three publications reporting 50 evaluations were included. The total number of RCTs assessed within evaluations was 16,604 (median per evaluation 123 (interquartile range (IQR) 77 to 226) published in a median of six (IQR 3 to 26) journals. Characteristics of the included RCT populations were variable, resulting in heterogeneity between included evaluations. Validity assessments of included studies resulted in largely unclear judgements. The included evaluations are not RCTs and less than 8% (4/53) of the evaluations reported adjusting for potential confounding factors.   Twenty-five of 27 outcomes assessing completeness of reporting in RCTs appeared to favour CONSORT-endorsing journals over non-endorsers, of which five were statistically significant. 'Allocation concealment' resulted in the largest effect, with risk ratio (RR) 1.81 (99% confidence interval (CI) 1.25 to 2.61), suggesting that 81% more RCTs published in CONSORT-endorsing journals adequately describe allocation concealment compared to those published in non-endorsing journals. Allocation concealment was reported adequately in 45% (393/876) of RCTs in CONSORT-endorsing journals and in 22% (329/1520) of RCTs in non-endorsing journals. Other outcomes with results that were significant include: scientific rationale and background in the 'Introduction' (RR 1.07, 99% CI 1.01 to 1.14); 'sample size' (RR 1.61, 99% CI 1.13 to 2.29); method used for 'sequence generation' (RR 1.59, 99% CI 1.38 to 1.84); and an aggregate score over reported CONSORT items, 'total sum score' (standardised mean difference (SMD) 0.68 (99% CI 0.38 to 0.98)). Evidence has accumulated to suggest that the reporting of RCTs remains sub-optimal. This review updates a previous systematic review of eight evaluations. The findings of this review are similar to those from the original review and demonstrate that, despite the general inadequacies of reporting of RCTs, journal endorsement of the CONSORT Statement may beneficially influence the completeness of reporting of trials published in medical journals. Future prospective studies are needed to explore the influence of the CONSORT Statement dependent on the extent of editorial policies to ensure adherence to CONSORT guidance.
AbstractList An overwhelming body of evidence stating that the completeness of reporting of randomised controlled trials (RCTs) is not optimal has accrued over time. In the mid-1990s, in response to these concerns, an international group of clinical trialists, statisticians, epidemiologists, and biomedical journal editors developed the CONsolidated Standards Of Reporting Trials (CONSORT) Statement. The CONSORT Statement, most recently updated in March 2010, is an evidence-based minimum set of recommendations including a checklist and flow diagram for reporting RCTs and is intended to facilitate the complete and transparent reporting of trials and aid their critical appraisal and interpretation. In 2006, a systematic review of eight studies evaluating the "effectiveness of CONSORT in improving reporting quality in journals" was published.BACKGROUNDAn overwhelming body of evidence stating that the completeness of reporting of randomised controlled trials (RCTs) is not optimal has accrued over time. In the mid-1990s, in response to these concerns, an international group of clinical trialists, statisticians, epidemiologists, and biomedical journal editors developed the CONsolidated Standards Of Reporting Trials (CONSORT) Statement. The CONSORT Statement, most recently updated in March 2010, is an evidence-based minimum set of recommendations including a checklist and flow diagram for reporting RCTs and is intended to facilitate the complete and transparent reporting of trials and aid their critical appraisal and interpretation. In 2006, a systematic review of eight studies evaluating the "effectiveness of CONSORT in improving reporting quality in journals" was published.To update the earlier systematic review assessing whether journal endorsement of the 1996 and 2001 CONSORT checklists influences the completeness of reporting of RCTs published in medical journals.OBJECTIVESTo update the earlier systematic review assessing whether journal endorsement of the 1996 and 2001 CONSORT checklists influences the completeness of reporting of RCTs published in medical journals.We conducted electronic searches, known item searching, and reference list scans to identify reports of evaluations assessing the completeness of reporting of RCTs. The electronic search strategy was developed in MEDLINE and tailored to EMBASE. We searched the Cochrane Methodology Register and the Cochrane Database of Systematic Reviews using the Wiley interface. We searched the Science Citation Index, Social Science Citation Index, and Arts and Humanities Citation Index through the ISI Web of Knowledge interface. We conducted all searches to identify reports published between January 2005 and March 2010, inclusive.SEARCH METHODSWe conducted electronic searches, known item searching, and reference list scans to identify reports of evaluations assessing the completeness of reporting of RCTs. The electronic search strategy was developed in MEDLINE and tailored to EMBASE. We searched the Cochrane Methodology Register and the Cochrane Database of Systematic Reviews using the Wiley interface. We searched the Science Citation Index, Social Science Citation Index, and Arts and Humanities Citation Index through the ISI Web of Knowledge interface. We conducted all searches to identify reports published between January 2005 and March 2010, inclusive.In addition to studies identified in the original systematic review on this topic, comparative studies evaluating the completeness of reporting of RCTs in any of the following comparison groups were eligible for inclusion in this review: 1) Completeness of reporting of RCTs published in journals that have and have not endorsed the CONSORT Statement; 2) Completeness of reporting of RCTs published in CONSORT-endorsing journals before and after endorsement; or 3) Completeness of reporting of RCTs before and after the publication of the CONSORT Statement (1996 or 2001). We used a broad definition of CONSORT endorsement that includes any of the following: (a) requirement or recommendation in journal's 'Instructions to Authors' to follow CONSORT guidelines; (b) journal editorial statement endorsing the CONSORT Statement; or (c) editorial requirement for authors to submit a CONSORT checklist and/or flow diagram with their manuscript. We contacted authors of evaluations reporting data that could be included in any comparison group(s), but not presented as such in the published report and asked them to provide additional data in order to determine eligibility of their evaluation. Evaluations were not excluded due to language of publication or validity assessment.SELECTION CRITERIAIn addition to studies identified in the original systematic review on this topic, comparative studies evaluating the completeness of reporting of RCTs in any of the following comparison groups were eligible for inclusion in this review: 1) Completeness of reporting of RCTs published in journals that have and have not endorsed the CONSORT Statement; 2) Completeness of reporting of RCTs published in CONSORT-endorsing journals before and after endorsement; or 3) Completeness of reporting of RCTs before and after the publication of the CONSORT Statement (1996 or 2001). We used a broad definition of CONSORT endorsement that includes any of the following: (a) requirement or recommendation in journal's 'Instructions to Authors' to follow CONSORT guidelines; (b) journal editorial statement endorsing the CONSORT Statement; or (c) editorial requirement for authors to submit a CONSORT checklist and/or flow diagram with their manuscript. We contacted authors of evaluations reporting data that could be included in any comparison group(s), but not presented as such in the published report and asked them to provide additional data in order to determine eligibility of their evaluation. Evaluations were not excluded due to language of publication or validity assessment.We completed screening and data extraction using standardised electronic forms, where conflicts, reasons for exclusion, and level of agreement were all automatically and centrally managed in web-based management software, DistillerSR(®). One of two authors extracted general characteristics of included evaluations and all data were verified by a second author. Data describing completeness of reporting were extracted by one author using a pre-specified form; a 10% random sample of evaluations was verified by a second author. Any discrepancies were discussed by both authors; we made no modifications to the extracted data. Validity assessments of included evaluations were conducted by one author and independently verified by one of three authors. We resolved all conflicts by consensus.For each comparison we collected data on 27 outcomes: 22 items of the CONSORT 2001 checklist, plus four items relating to the reporting of blinding, and one item of aggregate CONSORT scores. Where reported, we extracted and qualitatively synthesised data on the methodological quality of RCTs, by scale or score.DATA COLLECTION AND ANALYSISWe completed screening and data extraction using standardised electronic forms, where conflicts, reasons for exclusion, and level of agreement were all automatically and centrally managed in web-based management software, DistillerSR(®). One of two authors extracted general characteristics of included evaluations and all data were verified by a second author. Data describing completeness of reporting were extracted by one author using a pre-specified form; a 10% random sample of evaluations was verified by a second author. Any discrepancies were discussed by both authors; we made no modifications to the extracted data. Validity assessments of included evaluations were conducted by one author and independently verified by one of three authors. We resolved all conflicts by consensus.For each comparison we collected data on 27 outcomes: 22 items of the CONSORT 2001 checklist, plus four items relating to the reporting of blinding, and one item of aggregate CONSORT scores. Where reported, we extracted and qualitatively synthesised data on the methodological quality of RCTs, by scale or score.Fifty-three publications reporting 50 evaluations were included. The total number of RCTs assessed within evaluations was 16,604 (median per evaluation 123 (interquartile range (IQR) 77 to 226) published in a median of six (IQR 3 to 26) journals. Characteristics of the included RCT populations were variable, resulting in heterogeneity between included evaluations. Validity assessments of included studies resulted in largely unclear judgements. The included evaluations are not RCTs and less than 8% (4/53) of the evaluations reported adjusting for potential confounding factors. Twenty-five of 27 outcomes assessing completeness of reporting in RCTs appeared to favour CONSORT-endorsing journals over non-endorsers, of which five were statistically significant. 'Allocation concealment' resulted in the largest effect, with risk ratio (RR) 1.81 (99% confidence interval (CI) 1.25 to 2.61), suggesting that 81% more RCTs published in CONSORT-endorsing journals adequately describe allocation concealment compared to those published in non-endorsing journals. Allocation concealment was reported adequately in 45% (393/876) of RCTs in CONSORT-endorsing journals and in 22% (329/1520) of RCTs in non-endorsing journals. Other outcomes with results that were significant include: scientific rationale and background in the 'Introduction' (RR 1.07, 99% CI 1.01 to 1.14); 'sample size' (RR 1.61, 99% CI 1.13 to 2.29); method used for 'sequence generation' (RR 1.59, 99% CI 1.38 to 1.84); and an aggregate score over reported CONSORT items, 'total sum score' (standardised mean difference (SMD) 0.68 (99% CI 0.38 to 0.98)).MAIN RESULTSFifty-three publications reporting 50 evaluations were included. The total number of RCTs assessed within evaluations was 16,604 (median per evaluation 123 (interquartile range (IQR) 77 to 226) published in a median of s
An overwhelming body of evidence stating that the completeness of reporting of randomised controlled trials (RCTs) is not optimal has accrued over time. In the mid-1990s, in response to these concerns, an international group of clinical trialists, statisticians, epidemiologists, and biomedical journal editors developed the CONsolidated Standards Of Reporting Trials (CONSORT) Statement. The CONSORT Statement, most recently updated in March 2010, is an evidence-based minimum set of recommendations including a checklist and flow diagram for reporting RCTs and is intended to facilitate the complete and transparent reporting of trials and aid their critical appraisal and interpretation. In 2006, a systematic review of eight studies evaluating the "effectiveness of CONSORT in improving reporting quality in journals" was published. To update the earlier systematic review assessing whether journal endorsement of the 1996 and 2001 CONSORT checklists influences the completeness of reporting of RCTs published in medical journals. We conducted electronic searches, known item searching, and reference list scans to identify reports of evaluations assessing the completeness of reporting of RCTs. The electronic search strategy was developed in MEDLINE and tailored to EMBASE. We searched the Cochrane Methodology Register and the Cochrane Database of Systematic Reviews using the Wiley interface. We searched the Science Citation Index, Social Science Citation Index, and Arts and Humanities Citation Index through the ISI Web of Knowledge interface. We conducted all searches to identify reports published between January 2005 and March 2010, inclusive. In addition to studies identified in the original systematic review on this topic, comparative studies evaluating the completeness of reporting of RCTs in any of the following comparison groups were eligible for inclusion in this review: 1) Completeness of reporting of RCTs published in journals that have and have not endorsed the CONSORT Statement; 2) Completeness of reporting of RCTs published in CONSORT-endorsing journals before and after endorsement; or 3) Completeness of reporting of RCTs before and after the publication of the CONSORT Statement (1996 or 2001). We used a broad definition of CONSORT endorsement that includes any of the following: (a) requirement or recommendation in journal's 'Instructions to Authors' to follow CONSORT guidelines; (b) journal editorial statement endorsing the CONSORT Statement; or (c) editorial requirement for authors to submit a CONSORT checklist and/or flow diagram with their manuscript. We contacted authors of evaluations reporting data that could be included in any comparison group(s), but not presented as such in the published report and asked them to provide additional data in order to determine eligibility of their evaluation. Evaluations were not excluded due to language of publication or validity assessment. We completed screening and data extraction using standardised electronic forms, where conflicts, reasons for exclusion, and level of agreement were all automatically and centrally managed in web-based management software, DistillerSR(®). One of two authors extracted general characteristics of included evaluations and all data were verified by a second author. Data describing completeness of reporting were extracted by one author using a pre-specified form; a 10% random sample of evaluations was verified by a second author. Any discrepancies were discussed by both authors; we made no modifications to the extracted data. Validity assessments of included evaluations were conducted by one author and independently verified by one of three authors. We resolved all conflicts by consensus.For each comparison we collected data on 27 outcomes: 22 items of the CONSORT 2001 checklist, plus four items relating to the reporting of blinding, and one item of aggregate CONSORT scores. Where reported, we extracted and qualitatively synthesised data on the methodological quality of RCTs, by scale or score. Fifty-three publications reporting 50 evaluations were included. The total number of RCTs assessed within evaluations was 16,604 (median per evaluation 123 (interquartile range (IQR) 77 to 226) published in a median of six (IQR 3 to 26) journals. Characteristics of the included RCT populations were variable, resulting in heterogeneity between included evaluations. Validity assessments of included studies resulted in largely unclear judgements. The included evaluations are not RCTs and less than 8% (4/53) of the evaluations reported adjusting for potential confounding factors.   Twenty-five of 27 outcomes assessing completeness of reporting in RCTs appeared to favour CONSORT-endorsing journals over non-endorsers, of which five were statistically significant. 'Allocation concealment' resulted in the largest effect, with risk ratio (RR) 1.81 (99% confidence interval (CI) 1.25 to 2.61), suggesting that 81% more RCTs published in CONSORT-endorsing journals adequately describe allocation concealment compared to those published in non-endorsing journals. Allocation concealment was reported adequately in 45% (393/876) of RCTs in CONSORT-endorsing journals and in 22% (329/1520) of RCTs in non-endorsing journals. Other outcomes with results that were significant include: scientific rationale and background in the 'Introduction' (RR 1.07, 99% CI 1.01 to 1.14); 'sample size' (RR 1.61, 99% CI 1.13 to 2.29); method used for 'sequence generation' (RR 1.59, 99% CI 1.38 to 1.84); and an aggregate score over reported CONSORT items, 'total sum score' (standardised mean difference (SMD) 0.68 (99% CI 0.38 to 0.98)). Evidence has accumulated to suggest that the reporting of RCTs remains sub-optimal. This review updates a previous systematic review of eight evaluations. The findings of this review are similar to those from the original review and demonstrate that, despite the general inadequacies of reporting of RCTs, journal endorsement of the CONSORT Statement may beneficially influence the completeness of reporting of trials published in medical journals. Future prospective studies are needed to explore the influence of the CONSORT Statement dependent on the extent of editorial policies to ensure adherence to CONSORT guidance.
Author Moher, David
Dias, Sofia
Weeks, Laura
Schulz, Kenneth F
Peters, Jodi
Turner, Lucy
Shamseer, Larissa
Altman, Douglas G
Plint, Amy C
Kober, Thilo
Author_xml – sequence: 1
  givenname: Lucy
  surname: Turner
  fullname: Turner, Lucy
  email: lturner@ohri.ca
  organization: Ottawa Hospital Research Institute, Ottawa, Canada. lturner@ohri.ca
– sequence: 2
  givenname: Larissa
  surname: Shamseer
  fullname: Shamseer, Larissa
– sequence: 3
  givenname: Douglas G
  surname: Altman
  fullname: Altman, Douglas G
– sequence: 4
  givenname: Laura
  surname: Weeks
  fullname: Weeks, Laura
– sequence: 5
  givenname: Jodi
  surname: Peters
  fullname: Peters, Jodi
– sequence: 6
  givenname: Thilo
  surname: Kober
  fullname: Kober, Thilo
– sequence: 7
  givenname: Sofia
  surname: Dias
  fullname: Dias, Sofia
– sequence: 8
  givenname: Kenneth F
  surname: Schulz
  fullname: Schulz, Kenneth F
– sequence: 9
  givenname: Amy C
  surname: Plint
  fullname: Plint, Amy C
– sequence: 10
  givenname: David
  surname: Moher
  fullname: Moher, David
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23152285$$D View this record in MEDLINE/PubMed
BookMark eNpdkMlOwzAQhi1URBd4hcrH9pASL3GSI4rYpEKlUiRuUZw41JVjB9s58Cy8LEa0EmIus33z69dMwUgbLQCYo3iF4hhfI8oSlCXZ6mkbhyDxqh84PgOTsMgjmpO30Z96DKbOHQKWI5RdgDEmKME4SybgqzDaGSWbyosGOl_pprKNg6aFVvTGeqnfobeyUg4uis3zy2a7W8JAQb8XsDZdr4QXWrh_Jz9NoEwnXdCtjfbWKBXKk9a22LklDKaVdPswlxp2opF1peDBDFYH6BKctyGJq2Oegde7213xEK0394_FzTqqaUpwxChqOKJJmyQ5a3DKeUZSQhjhWZo3NOVMcMbiCrUcYSbiFiWU0jYTORcI1y2egcWvbm_NxyCcL4PrWihVaWEGVyKUooyRPE0DOj-iAw92y97KrrKf5emh-BsfO32P
CitedBy_id crossref_primary_10_1186_s13063_018_2503_0
crossref_primary_10_1002_14651858_MR000035_pub2
crossref_primary_10_1159_000495294
crossref_primary_10_1002_mpr_1939
crossref_primary_10_1093_icvts_ivv154
crossref_primary_10_3390_women5020017
crossref_primary_10_3389_fvets_2023_1137774
crossref_primary_10_1002_uog_18833
crossref_primary_10_1186_s12905_023_02463_4
crossref_primary_10_3389_fcvm_2020_592834
crossref_primary_10_1186_s12874_023_01922_8
crossref_primary_10_12688_f1000research_18453_2
crossref_primary_10_12688_f1000research_18453_1
crossref_primary_10_1093_mmy_myw133
crossref_primary_10_1136_bmjopen_2017_020064
crossref_primary_10_2341_17_060_L
crossref_primary_10_1136_bmjopen_2021_054777
crossref_primary_10_2196_21700
crossref_primary_10_1136_bmjopen_2021_050056
crossref_primary_10_1186_s12874_020_01076_x
crossref_primary_10_3389_fneur_2019_00991
crossref_primary_10_1186_s13643_017_0514_7
crossref_primary_10_1080_17437199_2015_1077155
crossref_primary_10_1186_s13063_018_2510_1
crossref_primary_10_1136_bmjopen_2019_032844
crossref_primary_10_1159_000517679
crossref_primary_10_1111_jocn_16132
crossref_primary_10_3389_fgene_2019_00958
crossref_primary_10_1111_epi_18047
crossref_primary_10_1177_0008417416648124
crossref_primary_10_1017_S0022215116009269
crossref_primary_10_1007_s12630_013_9895_9
crossref_primary_10_1002_ejhf_3289
crossref_primary_10_1136_bmjopen_2013_003556
crossref_primary_10_1186_s13063_020_04462_4
crossref_primary_10_1371_journal_pmed_1001910
crossref_primary_10_1136_bmjopen_2013_003436
crossref_primary_10_1001_jamanetworkopen_2023_17665
crossref_primary_10_1007_s11096_023_01612_x
crossref_primary_10_1001_jamanetworkopen_2025_29418
crossref_primary_10_2196_22500
crossref_primary_10_1186_s12966_018_0741_x
crossref_primary_10_2196_63723
crossref_primary_10_1016_j_ejim_2016_10_008
crossref_primary_10_1111_jcpe_12572
crossref_primary_10_3389_fpubh_2023_1236402
crossref_primary_10_5812_jjcdc_84757
crossref_primary_10_1016_j_eururo_2016_08_001
crossref_primary_10_1038_s41386_024_01973_5
crossref_primary_10_1016_j_zefq_2014_09_022
crossref_primary_10_1155_2022_3288948
crossref_primary_10_1186_s12889_023_17014_7
crossref_primary_10_1111_eve_13897
crossref_primary_10_1186_s12891_024_08241_z
crossref_primary_10_1007_s10143_025_03516_y
crossref_primary_10_1016_j_math_2014_07_011
crossref_primary_10_1111_hir_12464
crossref_primary_10_1159_000540641
crossref_primary_10_1371_journal_pmed_1001885
crossref_primary_10_1016_j_ctim_2014_01_003
crossref_primary_10_1007_s11229_022_03765_0
crossref_primary_10_1016_j_ijnurstu_2015_10_017
crossref_primary_10_1111_vru_13396
crossref_primary_10_1136_bmjopen_2019_036148
crossref_primary_10_3389_fphar_2022_1106957
crossref_primary_10_1186_s12916_016_0587_5
crossref_primary_10_1136_bmjopen_2017_016117
crossref_primary_10_1186_s13012_015_0235_z
crossref_primary_10_1080_02687038_2016_1178022
crossref_primary_10_1136_bjsports_2013_092296
crossref_primary_10_1186_s12888_019_2411_1
crossref_primary_10_3389_fneur_2024_1453183
crossref_primary_10_1002_14651858_CD006531_pub2
crossref_primary_10_1080_26408066_2020_1724226
crossref_primary_10_1136_bmjopen_2017_020580
crossref_primary_10_36377_1726_7242_2022_20_2_136_143
crossref_primary_10_1155_2022_3178154
crossref_primary_10_1155_2013_972471
crossref_primary_10_1186_s13063_017_1859_x
crossref_primary_10_25100_cm_v44i4_1475
crossref_primary_10_3389_fpsyg_2025_1576381
crossref_primary_10_1136_bmjopen_2016_012140
crossref_primary_10_7759_cureus_30748
crossref_primary_10_1038_s41598_024_72130_7
crossref_primary_10_1007_s10916_022_01856_6
crossref_primary_10_2196_37255
crossref_primary_10_5812_ircmj_60508
crossref_primary_10_1136_bmj_2024_081124
crossref_primary_10_1111_wrr_12087
crossref_primary_10_1007_s00784_025_06168_w
crossref_primary_10_1136_bmjopen_2018_021753
crossref_primary_10_1186_s12888_023_04753_5
crossref_primary_10_1136_bmjopen_2018_022603
crossref_primary_10_1111_irv_13283
crossref_primary_10_1136_bmjopen_2017_016455
crossref_primary_10_1186_s13054_024_05175_9
crossref_primary_10_3390_ijerph18168649
crossref_primary_10_1016_j_rce_2015_05_004
crossref_primary_10_1159_000360546
crossref_primary_10_1136_bmjopen_2020_040183
crossref_primary_10_1080_15323269_2018_1509196
crossref_primary_10_1136_bmjopen_2018_028382
crossref_primary_10_1136_bmjopen_2019_030981
crossref_primary_10_1159_000497423
crossref_primary_10_2196_34273
crossref_primary_10_1007_s11292_013_9180_5
crossref_primary_10_1136_bmjopen_2022_068173
crossref_primary_10_1007_s00784_021_04198_8
crossref_primary_10_1001_jamanetworkopen_2024_41372
crossref_primary_10_1136_bmj_n857
crossref_primary_10_1186_s13063_020_4195_5
crossref_primary_10_1093_ejo_cjaf026
crossref_primary_10_1136_bmjopen_2015_008007
crossref_primary_10_3389_fimmu_2024_1429895
crossref_primary_10_5312_wjo_v8_i1_1
crossref_primary_10_1016_j_rceng_2015_08_004
crossref_primary_10_1007_s00134_013_2947_3
crossref_primary_10_1007_s12630_013_9973_z
crossref_primary_10_1136_bmjqs_2022_014727
crossref_primary_10_1136_bmjopen_2017_017551
crossref_primary_10_1002_acr_23265
crossref_primary_10_1111_ajo_12233
crossref_primary_10_1007_s12603_016_0825_8
crossref_primary_10_1159_000542108
crossref_primary_10_1177_0741932516652893
crossref_primary_10_1080_00031305_2022_2143897
crossref_primary_10_1111_inm_13390
crossref_primary_10_7326_M14_2385
crossref_primary_10_1007_s40279_025_02187_5
crossref_primary_10_1371_journal_pone_0155078
crossref_primary_10_1136_bmjopen_2021_049093
crossref_primary_10_1186_s13643_025_02901_4
crossref_primary_10_1007_s00784_025_06189_5
crossref_primary_10_1186_s13643_022_02048_6
crossref_primary_10_1007_s40883_019_00141_2
crossref_primary_10_1016_j_jelekin_2025_102994
crossref_primary_10_1002_14651858_CD012654_pub2
crossref_primary_10_1007_s00520_024_08415_4
crossref_primary_10_1007_s00103_014_2065_6
crossref_primary_10_1080_17483107_2024_2442710
crossref_primary_10_1136_bmjopen_2019_032024
crossref_primary_10_1016_j_ctrv_2018_06_008
crossref_primary_10_1111_pme_12404
crossref_primary_10_7759_cureus_34353
crossref_primary_10_1111_jnu_12943
crossref_primary_10_1016_j_rbmo_2014_10_013
crossref_primary_10_1186_s12875_021_01473_1
crossref_primary_10_1007_s11192_022_04542_z
crossref_primary_10_1080_08989621_2021_1989676
crossref_primary_10_1371_journal_pone_0087987
crossref_primary_10_1007_s00784_023_05241_6
crossref_primary_10_1186_s13643_017_0643_z
crossref_primary_10_1001_jamanetworkopen_2023_36023
crossref_primary_10_1002_ejhf_3229
crossref_primary_10_1136_bmjebm_2019_111309
crossref_primary_10_1515_hmbci_2018_0020
crossref_primary_10_1002_14651858_CD011006_pub4
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1002/14651858.MR000030.pub2
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1469-493X
ExternalDocumentID 23152285
Genre Research Support, Non-U.S. Gov't
Systematic Review
Journal Article
GrantInformation_xml – fundername: Medical Research Council
  grantid: MR/J004871/1
GroupedDBID ---
53G
5GY
7PX
9HA
ABJNI
ACGFO
ACGFS
AENEX
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AYR
CGR
CUY
CVF
D7G
ECM
EIF
HYE
NPM
OEC
OK1
P2P
RWY
WOW
ZYTZH
7X8
ID FETCH-LOGICAL-c4732-641db145f5596d27bb8373363b879d47b6eb660a1fb126e0f15444f8e9be12cf2
IEDL.DBID 7X8
ISICitedReferencesCount 620
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000312198800020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1469-493X
IngestDate Fri Jul 11 08:43:52 EDT 2025
Sat Jun 28 01:33:50 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4732-641db145f5596d27bb8373363b879d47b6eb660a1fb126e0f15444f8e9be12cf2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ObjectType-Undefined-4
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/7386818
PMID 23152285
PQID 1171863977
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1171863977
pubmed_primary_23152285
PublicationCentury 2000
PublicationDate 2012-11-14
PublicationDateYYYYMMDD 2012-11-14
PublicationDate_xml – month: 11
  year: 2012
  text: 2012-11-14
  day: 14
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Cochrane database of systematic reviews
PublicationTitleAlternate Cochrane Database Syst Rev
PublicationYear 2012
SSID ssj0039118
Score 2.5981069
SecondaryResourceType review_article
Snippet An overwhelming body of evidence stating that the completeness of reporting of randomised controlled trials (RCTs) is not optimal has accrued over time. In the...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage MR000030
SubjectTerms Checklist - standards
Periodicals as Topic - standards
Publishing - standards
Randomized Controlled Trials as Topic - standards
Reference Standards
Title Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals
URI https://www.ncbi.nlm.nih.gov/pubmed/23152285
https://www.proquest.com/docview/1171863977
Volume 11
WOSCitedRecordID wos000312198800020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS-QwFA66s4gv7sXrritZ2If1oc7knj7JMjj44IzijjBvQ3ODAW1Hq_4Z_6wnberigyDsS2khCU16evLlfCf5EPrllWWFcCIL1oiMcyWzQlOWERdswYJmxDdH5p-pyUTPZvlFCrjVKa2y84mNo3aVjTHyPiHgRSMLpY6Xt1lUjYrsapLQWEU9BlAmpnSp2QuLwOBH1u3uoqikxmbdDuEB7ZOoAa6FPho3imtsELtP34aZzXQz-vS_L_oZbSSgif-0lvEFrfjyK1obJyp9Ez1Fqc7qehFX_A53EYUaVwG3PALMabjR9Kjx7-H55O_55fQQQykMkBE3megRb4OjfF0lPkCpCuwH2k2Z8Ndw27V1OZzWh3iZ0vEdXpT4pmWLcDLsegtdjU6mw9MsKTVklitGM8mJM4SLAOsT6agyBta9jElmtModV0Z6I-WgIMEQKv0gxDOAeNA-N55QG-g2-lBWpd9FuCC2UIURNs8ND8Rpp4UMThMVADkJuod-dsM-h55EeqMoffVQz_8N_B7aab_dfNke2TEHFAtAU4tv76j9Ha0DKqJxwyHh-6gXoN_-B_poH-8X9d1BY2JwnVyMnwEELN08
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Consolidated+standards+of+reporting+trials+%28CONSORT%29+and+the+completeness+of+reporting+of+randomised+controlled+trials+%28RCTs%29+published+in+medical+journals&rft.jtitle=Cochrane+database+of+systematic+reviews&rft.au=Turner%2C+Lucy&rft.au=Shamseer%2C+Larissa&rft.au=Altman%2C+Douglas+G&rft.au=Weeks%2C+Laura&rft.date=2012-11-14&rft.issn=1469-493X&rft.eissn=1469-493X&rft.volume=11&rft.spage=MR000030&rft_id=info:doi/10.1002%2F14651858.MR000030.pub2&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1469-493X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1469-493X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1469-493X&client=summon